Rastall Health Services Ltd 15175217 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is medical practice. Digita Accounts Production Advanced 6.30.9574.0 true 15175217 2024-11-01 2025-10-31 15175217 2025-10-31 15175217 core:RetainedEarningsAccumulatedLosses 2025-10-31 15175217 core:ShareCapital 2025-10-31 15175217 core:CurrentFinancialInstruments 2025-10-31 15175217 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 15175217 core:OfficeEquipment 2025-10-31 15175217 bus:SmallEntities 2024-11-01 2025-10-31 15175217 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 15175217 bus:FullAccounts 2024-11-01 2025-10-31 15175217 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 15175217 bus:RegisteredOffice 2024-11-01 2025-10-31 15175217 bus:Director1 2024-11-01 2025-10-31 15175217 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 15175217 core:OfficeEquipment 2024-11-01 2025-10-31 15175217 countries:EnglandWales 2024-11-01 2025-10-31 15175217 2024-10-31 15175217 core:OfficeEquipment 2024-10-31 15175217 2023-11-01 2024-10-31 15175217 2024-10-31 15175217 core:RetainedEarningsAccumulatedLosses 2024-10-31 15175217 core:ShareCapital 2024-10-31 15175217 core:CurrentFinancialInstruments 2024-10-31 15175217 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 15175217 core:OfficeEquipment 2024-10-31 iso4217:GBP xbrli:pure

Filleted

Registration number: 15175217

Rastall Health Services Ltd
Annual Report and Unaudited Financial Statements
for the Year Ended 31 October 2025

Rastall Health Services Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Financial Statements | 3 to 6

Rastall Health Services Ltd

Company Information

Director | Dr P Rastall

Registered office | 101 Bronwydd Road Carmarthen SA31 2AR

Rastall Health Services Ltd

(Registration number: 15175217)
Balance Sheet as at 31 October 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 5 | 1,770 | 2,631
Current assets |  |  |
Debtors | 6 | 7,093 | 14,161
Cash at bank and in hand |  | 19,237 | 16,957
|  | 26,330 | 31,118
Creditors: Amounts falling due within one year | 7 | (13,018) | (25,244)
Net current assets |  | 13,312 | 5,874
Net assets |  | 15,082 | 8,505
Capital and reserves |  |  |
Called up share capital |  | 103 | 103
Profit and loss account |  | 14,979 | 8,402
Total equity |  | 15,082 | 8,505

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 5 March 2026

......................................... Dr P Rastall Director |  |

Rastall Health Services Ltd

Notes to the Financial Statements for the Year Ended 31 October 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
101 Bronwydd Road
Carmarthen
SA31 2AR

These financial statements were authorised for issue by the director on 5 March 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Rastall Health Services Ltd

Notes to the Financial Statements for the Year Ended 31 October 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office equipment | 25% reducing balance basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 4 (2024 - 4).

Rastall Health Services Ltd

Notes to the Financial Statements for the Year Ended 31 October 2025

4 | Profit before tax

Arrived at after charging/(crediting)

| 2025 £ | 2024 £
Depreciation expense | 268 | 600

5 | Tangible assets

| Office equipment £ | Total £
Cost or valuation
At 1 November 2024 | 3,231 | 3,231
Additions | 1,158 | 1,158
Disposals | (2,057) | (2,057)
At 31 October 2025 | 2,332 | 2,332
Depreciation
At 1 November 2024 | 600 | 600
Charge for the year | 268 | 268
Eliminated on disposal | (306) | (306)
At 31 October 2025 | 562 | 562
Carrying amount
At 31 October 2025 | 1,770 | 1,770
At 31 October 2024 | 2,631 | 2,631

6 | Debtors

| 2025 £ | 2024 £
Trade debtors | 7,090 | 14,158
Other debtors | 3 | 3
| 7,093 | 14,161

Rastall Health Services Ltd

Notes to the Financial Statements for the Year Ended 31 October 2025

7 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Directors' loan accounts | 9 | 1,895 | 4,554
Outstanding defined contribution pension costs |  | - | 14
Corporation tax liability |  | 10,175 | 19,777
Other creditors |  | 948 | 899
|  | 13,018 | 25,244

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
103 Ordinary shares of £1 each of £1 each | 103 | 103 | 103 | 103

9 | Related party transactions

Other transactions with directors

At the balance sheet date, the director, Dr P Rastall, was owed £1,894.53 (2024: £4,553.81) from the company. The loan is interest free and repayable on demand.